Harnessing NKT cells for therapeutic applications.

Cerundolo, V; Salio, M

Cerundolo, V; Salio, M.

Affiliation

Cerundolo V; Cancer Research UK Tumour Immunology Group, The Weatherall Institute of Molecular Medicine, Oxford OX3 9DS, UK. vincenzo.cerundolo@imm.ox.ac.uk

Curr Top Microbiol Immunol ; 314: 325-40, 2007.

Article in En | MEDLINE | ID: mdl-17593667

Subject(s)

Adjuvants, Immunologic; Autoimmune Diseases/immunology; Killer Cells, Natural/immunology; Animals; Cell Differentiation; Dendritic Cells/cytology; Dendritic Cells/immunology; Humans; Lymphocyte Activation; Mice; Vaccination

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Killer Cells, Natural / Adjuvants, Immunologic Limits: Animals / Humans Language: En Journal: Curr Top Microbiol Immunol Year: 2007 Type: Article Affiliation country: United kingdom

Search on Google

XML

PubMed Links